ACRES Announces Strategic Alliance with Atlantis Global Research Institute
Posted September 26, 2013 by Mary Tobin
ACRES Global Network of high performing clinical research sites will begin registering all of AGRI’s national and international research sites in the ACRES network. The ACRES/AGRI Strategic Alliance brings synergy to both organizations’ efforts to improve the world of biomedical research.
The Atlantis Global Research Institute (AGRI) today announced that it will work with the Alliance for Clinical Research Excellence and Safety (ACRES) to accelerate development of the ACRES Global Network, a group of high performing sites connected through a shared technology platform as part of an open and global system for clinical research. To that end, AGRI has joined ACRES as a Strategic Alliance partner and will immediately begin registering all of its global research sites in the ACRES network.
AGRI Managing Director, Robert Wallace, noted, “We are elated to become an ACRES Alliance member and to have our national and international research sites join the ACRES global network. We believe that medical innovation and progress come from the formation of synergistic partnerships that enable conduct of clinical trials globally through a centralized process and, most importantly, provide access to novel treatment options to patients across the globe. Our alliance with ACRES allows this vision to become a reality.”
AGRI has developed a proprietary structure that allows the bio-pharmaceutical, pharmaceutical, device and diagnostic industry to conduct their clinical trials in a more time and cost-efficient manner. AGRI’s methodology is propelling the clinical trial industry forward by reducing the overall time and costs involved with conducting clinical trials.
Founded in 2012 AGRI has already established itself as one of the fastest growing and most innovative global research institutes worldwide, with over 100 research sites across the globe.
“Like ACRES, AGRI is a young and rapidly growing organization, and we share a new vision for the future of clinical research,” said ACRES President and CEO, Dr. Greg Koski. “We are delighted that AGRI is among the first global clinical research organizations to partner with ACRES to begin building a truly global system of research sites dedicated to enhancing excellence and safety in clinical trials world-wide for the benefit of all.”
Leveraging global expertise to create a connected world of clinical research that is safer, better, faster
ACRES, a global non-profit organization based in Cambridge, Massachusetts, is working in the public interest to build a comprehensive, sustainable and shareable global system for clinical research. By bringing together experts, stakeholders and like-minded organizations, ACRES is creating and implementing systems solutions that will enhance safety, data quality and integrity in an efficient, collaborative and cost effective manner to improve the health and lives of people everywhere. http://www.acresglobal.net
Atlantis Global Research Institute (AGRI) is pioneering changes in how global clinical research is conducted by developing synergistic partnerships, collaborations, and alliances to produce quality results in a more timely and cost-efficient manner.
For the original version on PRWeb visit here.
Dr. Mary F. Tobin firstname.lastname@example.org